Works matching IS 02692813 AND DT 2019 AND VI 50 AND IP 2
Results: 17
Editorial: the increasing burden of microscopic colitis.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Corrigendum.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 234, doi. 10.1111/apt.15361
- Publication type:
- Article
Letter: programmed cell death protein‐1 (PD‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world cohort—more questions than answers. Authors' reply
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 231, doi. 10.1111/apt.15334
- By:
- Publication type:
- Article
Letter: impact of hepatitis B core‐related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues—further clarifications needed. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 233, doi. 10.1111/apt.15332
- By:
- Publication type:
- Article
Editorial: reciprocal interaction between HCV direct‐acting anti‐virals (DAA) and hepatocellular carcinoma (HCC)—a negative impact of HCC on sustained virologic response not of DAA on HCC.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Systematic review with meta‐analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 132, doi. 10.1111/apt.15325
- By:
- Publication type:
- Article
Letter: programmed cell death protein‐1 (PD‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world cohort—more questions than answers.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 230, doi. 10.1111/apt.15322
- By:
- Publication type:
- Article
Determinants of diagnostic delay in autoimmune atrophic gastritis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 167, doi. 10.1111/apt.15317
- By:
- Publication type:
- Article
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 193, doi. 10.1111/apt.15316
- By:
- Publication type:
- Article
Letter: impact of hepatitis B core‐related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues—further clarifications needed.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 232, doi. 10.1111/apt.15254
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. i, doi. 10.1111/apt.14881
- Publication type:
- Article
Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005‐2013.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 176, doi. 10.1111/apt.15315
- By:
- Publication type:
- Article
Gastric bypass surgery in the treatment of gastro‐oesophageal reflux symptoms.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 159, doi. 10.1111/apt.15274
- By:
- Publication type:
- Article
Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 144, doi. 10.1111/apt.15314
- By:
- Publication type:
- Article
High risk of clinical events in untreated HBeAg‐negative chronic hepatitis B patients with high viral load and no significant ALT elevation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 215, doi. 10.1111/apt.15311
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 121, doi. 10.1111/apt.15306
- By:
- Publication type:
- Article
The association between hepatocellular carcinoma and direct‐acting anti‐viral treatment in patients with decompensated cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 204, doi. 10.1111/apt.15296
- By:
- Publication type:
- Article